<DOC>
	<DOCNO>NCT00311506</DOCNO>
	<brief_summary>This observational study conduct approximately 25 site United States . Approximately 25 subject severe obstructive CF lung disease ( FVC &lt; 40 % predict ) enrol .</brief_summary>
	<brief_title>A Study Determine Variability 6-Minute Walk Test Cystic Fibrosis Subjects With Advanced Lung Disease</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<criteria>Able provide write informed consent Males females &gt; =14 year old Visit 3 A proven diagnosis CF evidence positive sweat test ( sweat sodium chloride &gt; 60 mEq/L quantitative pilocarpine iontophoresis ) , genotype clinical symptom consistent diagnosis CF Able perform reproducible spirometry maneuver Visit 1 accordance American Thoracic Society ( coefficient variation three FEV1 maneuver &lt; =0.2 ) FVC &lt; 40 % predict height , age sex Visit 1 On stable regimen chest physiotherapy ( CPT ) begin least 7 day prior Visit 1 Able complete 6minute walk test Visit 1 Use investigational drug device within 28 day prior Visit 1 Experiencing episode severe acute respiratory failure , determine investigator</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Pulmozyme</keyword>
</DOC>